



























































































































When you know a thing, to hold that you know it; and when you not know a thing, to allow that you do not know it 
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Figure 5.4a: The effects of 20nm PBs (12.5-100µg.ml-1) 		189
either in the presence or absence of 10% FCS 
on the metabolic activity (MTT assay) of 
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J774.A1 cells at four hours.  
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on the metabolic activity (MTT assay) of 
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Figure 5.5a: Percentage LDH release from J774.A1 cells treated 	193
with 20nm PBs (12.5-100µg.ml-1) either in the 
presence or absence of 10% FCS at two hours.
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over 2 hours. 
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AM 			- Acetoxy methyl
ANOVA 		- Analysis of Variance
AOT			- Sodium dioctyl sulfosuccinate
AP-1			- Activator protein-1
ATP 			- Adenosine 5’-triphosphate
Au			- Gold
BAL 			- Bronchoalveolar Lavage
BALB/c		- An albino strain of laboratory mouse
BEAS-2B cells	- Human bronchial epithelial cell-line
BSA 			- Bovine Serum Albumin




CB 			- Carbon Black
Cd			- Cadmium
Cd2+ 			- Cadmium ions
CdCl2			- Cadmium Chloride
CdSe 			- Cadmium Selenide
CdTe 			- Cadmium Telluride
cm2			- squared centimetre
CME			- Clathrin-mediated endocytosis
CNS 			- Central Nervous System
CNTs			- Carbon nanotubes
COOH 		- Carboxylate
COPD 		- Chronic Obstructive Pulmonary Disease
CPC			- Cetylpyridinium chloride
CST			- Council for Science and Technology





DEFRA 		- Department for Environment, Food and Rural Affairs
DEP			- Diesel exhaust particles
DHE 			- Dihydroethidium
DLS 			- Dynamic Light Scattering
DMEM 		- Dulbecco’s Modified Eagle’s Medium
DMSO 		- Dimethyl sulfoxide
DM1A			- Purified Mouse clone Immunoglobulin
DNA			- Deoxyribose nucleic acid
DPX			- Distyrene di-n-butylphthalate xylene
DTT			- Dithiothreitol
ECACC 		- European collection of cell cultures
EDTA 		- Tetra ethylene diamine tetraacetic acid
EDX 			- Energy Dispersive X-ray
EEA-1 		- Early Endocytic antigen-1
EELS			- Electron energy loss spectroscopy
EFTEM 		- Energy Filtering Transmissaion Electron Microscopy 
EGTA 		- Ethylene glycol tetraacetic acid
EL-4 cells		- Mouse lymphoma cell-line
ELISA 		- Enzyme linked immunosorbant assay
EMEM 		- Eagle’s minimum essential medium
ER 			- Endoplasmic Reticulum
ESF 			- European Science Foundation
F-68 CTAB		- Block Co-polymer/surfactant (F-68) Cetyltrimethyl   
                                   ammonium bromide
FBS 			- Foetal bovine serum
FCS 			- Foetal calf serum
Fe			- Iron
FeCl2			- Iron Chloride
FEG-SEM 		- Field Emission Gun Scanning Electron Microscope
FL-1 (Flow Cytometry) -	Detector Filter Laser 1 (530nm ± 30nm) 
FL-2 (Flow Cytometry) - Detector Filter Laser 2 (585nm ± 30nm)
FSC 			- Forward scatter mode (Flow Cytometry)
GI 			- Gastrointestinal tract
GMFI 			- Geometric mean fluorescent intensity
GSH 			- Reduced Glutathione
GSSG 		- Oxidised Glutathione
GTPases		- Guanine nucleotide ases
H			- Hydrogen
HCl 			- Hydrochloric acid 
Hela cells		- Immortal cell-line, derived from cervical cancer cells
HeNe 			- Helium-Neon laser
HepG2 cells		- Human hepatocellular carcinoma cell-line
HEPES		- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HO-1 			- Heme-oxygenase -1
HSF-42 cells		- human skin fibroblast cell-line
i.v. 			- Intercostal vein
ICP-MS 		- Inductively coupled plasma mass spectroscopy





IMR-32 cells		- Human neuroblastoma cell-line
IMR-90 cells		- Human lung fibroblast cell-line
192Ir			- Iridium-192
J774.A1 cells	- Murine ‘macrophage-like’ cell-line
keV 			- kilo electron Volts
KHCO3 		- Potassium Bicarbonate
KOH 			- Potassium Hydroxide




MCF-7 cells		- Human epithelial breast adenocarcinoma cell-line
MDA-MB-231 cells	- Breast cancer cell-line
MIP-2			- Macrophage Inflammatory Protein-2
MM6 cells		- Monomac 6 human macrophage cell-line
MPA 			- Mercaptopropianic Acid
MTT			- 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
  bromide
MUA 			- Mercaptoundecanoic acid
mV 			- milliVolts
M1			- Electronic Marker 1 (Flow Cytometry)
M2			- Electronic Marker 2 (Flow Cytometry)
n			​- number of ethylene glycol subunits (PEG)
N.A. 			- Numerical aperture
N9 cells		- Microglial cell-line
NAC 			- N-acetyl-L-cysteine 
NAD+ 			- Nicotinamide adenine dinucleotide
NADH 		- Nicotinamide adenine nucleotide
NADPH oxidase	- nicotinamide adenine dinucleotide phosphate-   
  oxidase
Na2B4O7·10H2O 	- Sodium borate
NaH2PO4.2H20 	- Sodium dihydrogen orthophosphate 
NaOH 		- Sodium Hydroxide 
ND 			- Not detectable
NEM 			- N-ethyl maleimide







O.S. 			- Organic Solvent Vehicle Mixture
OD 			- Optical Density
OPT 			- Ophthaldehyde 
P/S 			- Penicillin/Streptomycin
PB 			- Polystyrene Bead
PBs 			- Polystyrene Beads
PBS 			- Phosphate buffered saline
PC12 cells		- Neuronal cell-line derived from the 
   pheochromocytoma of a rat adrenal medulla
PEF 			- Peak Expiratory Flow
PEG 			- Polyethylene glycol
PEI 			- Polyethylenimine
PI 			- Propidium Iodide
PM			- Particulate Matter
PMNs			- Polymorphonuclear leukocytes
PM10 			- Particulate Matter of <10µm
POC-R		- Aliuminium, black anodised perfusion, open and 
   closed cultivation chamber system
PTFE 			- Polytetrafluoroethylene
QD 			- Quantum dot
QDs 			- Quantum dots
RAW 264.7 cells	- Macrophage-like, Abelson leukemia virus cell-line
ROS 			- Reactive oxygen species
RPMI 			- Roswell Park Memorial Institute
SCENIHR 		- Scientific Committee on Emerging and Newly 
 		   Identified Health Risks
SDS			- Sodium Dodecyl Sulfate
S.E.M. 		- Scanning electron microscope/microscopy
SEM 			- Standard Error of the Mean
SPCM 		- Single photon counting module
SPIONs 		- Superparamagnetic iron oxide nanoparticles
SSA			- Sheep serum albumin
SSC 			- Side Scatter Mode (Flow cytometry)
SWCNTs 		- Single walled Carbon Nanotubes
T.E.M. 		- Transmission electron microscope/microscopy
TiO2 			- Titanium dioxide
TNF- 		- Tumour necrosis factor-alpha
TOP 			- Trioctyll phosphine
TOPO 		- Trioctyll phosphine oxide
Uf			- Ultrafine
ufCB 			- Ultrafine carbon black
Vero cells		- African green monkey’s kidney cells
WD 			- Working Distance
WHO EHC		- World Health Organisation Environmental Health 
  	   Criteria
ZnS 			- Zinc Sulphide
Ø			- Diameter
>			- greater than
≥			- greater than or equal to
<			- less than
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Please find a supplementary data DVD located inside the back cover of this PhD thesis. 

Contained on the DVD are data sets corresponding with results presented in chapter three.  The specific data sets on the DVD are;

1.	Figure 3.1 - Example of cell auto-fluorescence - live imaging movie1
2.	Figure 3.7 c-f - All confocal z-stack images2
3.	Figure 3.7g - All IMARIS® 3D image restoration movies1
4.	Figure 3.8 a-f - All live imaging movies1

1 All images can be viewed through Microsoft Windows Media Player®

2 In order to view the confocal z-stack images, it is necessary to download the LSM 5 image browser software (also located on the data DVD). This programme contains no viruses and is safe to download onto any computer which has a current version of Microsoft Windows®                         (2000 (Millenium)®, XP®, Vista®). To install this imaging software onto any computer, follow the procedure described below.

1)	Click on folder entitled LSM 5 image browser software
2)	Click on folder entitled LSM 5 image browser
3)	Click on folder entitled image browser
4)	Click on icon entitled ‘INST_IB’
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